Pooja Saxena

机构：Medicago (Canada), McGill University · ORCID：0000-0002-3100-9740

发表论文 9 篇 · 总被引 130 次 · h-index 6

代表论文

• Plant molecular farming in the wake of the closure of Medicago Inc (2023 · Nature Biotechnology · 被引 37)
• Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities (2022 · npj Vaccines · 被引 37)
• A genome‐edited N. benthamiana line for industrial‐scale production of recombinant glycoproteins with targeted N‐glycosylation (2023 · Biotechnology Journal · 被引 20)
• Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity (2022 · npj Vaccines · 被引 18)
• An oligosaccharyltransferase from Leishmania donovani increases the N-glycan occupancy on plant-produced IgG1 (2023 · Frontiers in Plant Science · 被引 7)
• Efficacy and Safety of a Plant-Based Virus-Like Particle Vaccine for COVID-19 Adjuvanted with AS03 (2022 · medRxiv · 被引 7)